General Information of Drug-Metabolizing Enzyme (DME ID: DME0422)
DME Name Estradiol 17-beta-dehydrogenase 2 (HSD17B2), Homo sapiens DME Info
UniProt ID
DHB2_HUMAN
EC Number    EC: 1.1.1.62     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
CH-OH donor oxidoreductase
NAD/NADP oxidoreductase
EC: 1.1.1.62
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification Healthy
               ICD-11: Healthy Click to Show/Hide the Full List of HOSPPI:        2 HOSPPI
                     Transcription-factor regulation
                            Transcription factor Sp1 (SP1) Health Activation
Uniprot ID
SP1_HUMAN
Interaction Name SP1-HSD17B2 interaction [1], [2]
Studied Cell Lines Human endometrial epithelial cell line
Ensembl ID
ENSG00000185591
Description Transcription factor Sp1 (SP1) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP1 and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
                            Transcription factor Sp3 (SP3) Health Activation
Uniprot ID
SP3_HUMAN
Interaction Name SP3-HSD17B2 interaction [1], [2]
Studied Cell Lines Human endometrial epithelial cell line
Ensembl ID
ENSG00000172845
Description Transcription factor Sp3 (SP3) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP3 and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2A00 Brain cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Multilayered rosettes embryonal tumour Moderate hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 2.75E-07; delta-beta: -2.63E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HSD17B2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B30 Lymphoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Lymphoma Moderate hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 1.60E-06; delta-beta: -2.55E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HSD17B2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B5F Uterine carcinosarcoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Uterine carcinosarcoma Significant hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 1.15E-02; delta-beta: -3.24E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B71 Gastric cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Gastric cancer Significant hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Adjacent Tissue Significant hypomethylation
p-value: 1.74E-02; delta-beta: -4.25E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2B90 Colorectal cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Colorectal cancer Moderate hypermethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypermethylation
p-value: 1.78E-03; delta-beta: 2.27E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the HSD17B2 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2C76 Endometrial cancer Click to Show/Hide the Full List of HOSPPI:        4 HOSPPI
                     Transcription-factor regulation
                            Retinoic acid receptor alpha (RARA) Endometrial cancer Activation
Uniprot ID
RARA_HUMAN
Interaction Name RARA-HSD17B2 interaction [1]
Studied Cell Lines Ishikawa and RL95-2 cell lines
Ensembl ID
ENSG00000131759
Description Retinoic acid receptor alpha (RARA) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between RARA and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
                            Retinoid X receptor alpha (RXRA) Endometrial cancer Activation
Uniprot ID
RXRA_HUMAN
Interaction Name RXRA-HSD17B2 interaction [1]
Studied Cell Lines Ishikawa and RL95-2 cell lines
Ensembl ID
ENSG00000186350
Description Retinoid X receptor alpha (RXRA) is reported to activate the transcription of HSD17B2 gene, which leads to an increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between RXRA and HSD17B2 can activate the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
                            Transcription factor Sp1 (SP1) Endometrial cancer Repression
Uniprot ID
SP1_HUMAN
Interaction Name SP1-HSD17B2 interaction [1]
Studied Cell Lines Ishikawa and RL95-2 cell lines
Ensembl ID
ENSG00000185591
Description Transcription factor Sp1 (SP1) is reported to repress the transcription of HSD17B2 gene, which leads to a decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP1 and HSD17B2 can repress the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
                            Transcription factor Sp2 (SP2) Endometrial cancer Repression
Uniprot ID
SP2_HUMAN
Interaction Name SP2-HSD17B2 interaction [1]
Studied Cell Lines Ishikawa and RL95-2 cell lines
Ensembl ID
ENSG00000167182
Description Transcription factor Sp2 (SP2) is reported to repress the transcription of HSD17B2 gene, which leads to a decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between SP2 and HSD17B2 can repress the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
               ICD-11: 2C82 Prostate cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Prostate cancer Moderate hypermethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypermethylation
p-value: 9.79E-04; delta-beta: 2.42E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the HSD17B2 gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2F9A Endocrine gland cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Craniopharyngioma Significant hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 3.15E-05; delta-beta: -3.20E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
      ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases
               ICD-11: 5A61 Pituitary gland hypofunction Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Chordoma Significant hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 6.13E-05; delta-beta: -4.08E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HSD17B2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can significantly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 5B81 Obesity Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Obesity Moderate hypomethylation
Interaction Name DNMT-HSD17B2 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 1.62E-12; delta-beta: -2.24E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HSD17B2 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Estradiol 17-beta-dehydrogenase 2. As a result, the interaction between DNMT and HSD17B2 can moderatly affect the drug-metabolizing process of Estradiol 17-beta-dehydrogenase 2.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
References
1 Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J Clin Endocrinol Metab. 2008 May;93(5):1915-23.
2 SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biol Reprod. 2006 Oct;75(4):605-14.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.